
What smart money is saying about Avantor, Inc.
2 funds in our archive have pitched Avantor, Inc. — most recently Broyhill Asset Management in December 2025.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Fund coverage · 2 theses
- Broyhill Asset ManagementDecember 2025
Avantor is a strategic life-sciences supplier with self-help levers amid an industry upturn despite execution issues.
Read the full thesis - The London Company Mid CapSeptember 2025
Avantor, Inc. (AVTR) is a leading provider of mission-critical products and services for the life sciences and biopharma industries, with a resilient business model and strong long-term growth potential despite near-term market challenges.
Read the full thesis
Read every full thesis on Avantor, Inc.
Unlock all 2 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→